BofA downgraded Editas Medicine (EDIT) to Underperform from Buy with a price target of $1, down from $13, after the company recently announced ...

Editas Medicine (EDIT – Research Report) received a Sell rating and price target from Bank of America Securities analyst Alec Stranahan on ...

The new version of DocSpace introduces new spaces for internal collaboration. A new variant allows functions to be integrated ...

The iPhone home screen is more customizable than ever before. Adding and resizing widgets or changing how app icons look is ...

TikTok hosted an invite-only creator summit in LA last week dedicated to long-form video but didn't mention the potential US ...